Phase I/II Study: Experience with the Late Onset of Acute Pancreatitis after the Start of Chemotherapy with Gemcitabine Plus nab-Paclitaxel for Metastatic Pancreatic Cancer

Gemcitabine plus nab-paclitaxel is the current standard chemotherapy for patients with metastatic pancreatic cancer. We conducted a phase I/II study in Japan, in which high response rates and manageable toxicity were observed. In this study, two patients were reported as experiencing pancreatitis du...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Intern Med
المؤلفون الرئيسيون: Ueno, Makoto, Nagashima, Fumio, Ueno, Hideki, Ikeda, Masafumi, Ohkawa, Shinichi, Mizuno, Nobumasa, Ioka, Tatsuya, Omuro, Yasushi, Nakajima, Takako Eguchi, Furuse, Junji
التنسيق: Artigo
اللغة:Inglês
منشور في: The Japanese Society of Internal Medicine 2019
الموضوعات:
Case Report
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6859393/
https://ncbi.nlm.nih.gov/pubmed/31243233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.2362-18
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة